Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: The Insulin Resistance Atherosclerosis Family Study

Liver International

Volumn 31, Issue 3, 2011, Pages 412-416

  Wagenknecht, Lynne E ^a   Palmer, Nicholette D ^a   Bowden, Donald W ^a   Rotter, Jerome I ^b   Norris, Jill M ^c   Ziegler, Julie ^a   Chen, Yii Der I ^b   Haffner, Steven ^d   Scherzinger, Ann ^e   Langefeld, Carl D ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c Department of Civil and Environmental Engineering at Colorado State University and the Department of Environmental and Occupational Health at the Colorado School of Public Health   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

African Americans; Computed tomography; Genetic epidemiology; Hepatic steatosis; Hispanic Americans; Non alcoholic fatty liver disease; PNPLA3

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HISPANIC; HUMAN; HUMAN GENETICS; LIVER; MALE; MULTICENTER STUDY; NONALCOHOLIC FATTY LIVER; PATATIN LIKE LIKE PHOSPHOLIPASE DOMAIN CONTAINING PROTEIN 3 GENE; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HISPANIC AMERICANS; HUMANS; INSULIN RESISTANCE; LIPASE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 79551552758     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2010.02444.x     Document Type: Article

References (19)

1. Wagenknecht LE, Scherzinger AL, Stamm ER, et al. Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort. Obesity 2009; 17: 1240-6.
2. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevelance of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387-95.
3. Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40: 1461-5.
4. Kotronen A, Johansson LE, Johansson LM, et al. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia 2009; 52: 1056-60.
5. Sookoian S, Castano GO, Burgueno AL, et al. A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity. J Lipid Res 2009; 50: 2111-6.
6. Rotman Y, Koh C, Zmuda JM, et al. The association of genetic variability in patatin-like phospholipase domain-containing protein (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology 2010; 52: 894-903.
7. Valenti L, Al-Serri A, Daly AK, et al. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 2010; 51: 1209-17.
8. Valenti L, Alisi A, Galmozzi E, et al. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology 2010; 52: 1274-80.
9. Henkin L, Bergman RN, Bowden DW, et al. Genetic epidemiology of insulin resistance and visceral adiposity: the IRAS Family Study Design and Methods. Ann Epidemiol 2003; 13: 211-7.
10. Wagenknecht LE, Mayer E, Rewers M, et al. The Insulin Resistance Atherosclerosis Study (IRAS): objectives, design, and recruitment results. Ann Epidemiol 1995; 5: 464-72.
11. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev 1985; 6: 45-86.
12. Davidson LE, Kuk JL, Church TS, Ross R. Protocol for measurement of liver fat by computed tomography. J Appl Physiol 2006; 100: 864-8.
13. Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 2003; 285: E906-16.
14. Kodama Y, Ng CS, Wu TT, et al. Comparison of CT methods for determining the fat content of the liver. Am Roentg Soc 2007; 188: 1307-12.
15. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63: 259-66.
16. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998; 62: 1198-211.
17. Santoro N, Kursawe R, D'Adamo E, et al. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology 2010; 52: 1281-90.
18. He S, McPhaul C, Li JZ, et al. A sequence variation (I148M) in PNPlA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem 2010; 285: 6706-15.
19. Hoekstra M, Li Z, Kruijt JK, et al. The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status. J Hepatol 2010; 52: 244-51.